Baby Botulism Outbreak: FDA Still Clueless on Cause and Prevention

Baby Botulism Outbreak: FDA’s Ongoing Quest for Answers

The Food and Drug Administration released an understated update on the baby botulism outbreak tied to ByHeart infant formula, yet the agency admits it still cannot pinpoint how spores entered the product or how to block a repeat.

“The FDA’s investigation into the root cause is ongoing with a focus on ingredients,” the agency said in a brief

statement posted on its website

. The comment, mirrored by Reuters, left three firms—ByHeart, its ingredient supplier, and the contract manufacturer—circling the blame without a public admission of fault.

Since the first case surfaced, ↓13 infants have been hospitalized, with several fatalities confirmed. The mystery deepens as traceability data show the contaminated batch originated from a single production line, yet no procedural lapse has been identified.

Regulators are now urging manufacturers to reevaluate sterilization protocols and supply‑chain audits, a call that echoes lessons learned during the recent pandemic when food‑safety gaps were exposed worldwide.